HY-P5284-1mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
HY-P5284-10mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
HY-P5284-5mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-50mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-1mL
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-W007599-100g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
HY-W007599-25g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
HY-W007599-50g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|